Details for New Drug Application (NDA): 021604
✉ Email this page to a colleague
NDA 021604 describes CHILDREN'S ELIXSURE, which is a drug marketed by Moberg Pharma North and is included in one NDA. Additional details are available on the CHILDREN'S ELIXSURE profile page.
The generic ingredient in CHILDREN'S ELIXSURE is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty-five suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
The generic ingredient in CHILDREN'S ELIXSURE is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty-five suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 021604
| Tradename: | CHILDREN'S ELIXSURE |
| Applicant: | Moberg Pharma North |
| Ingredient: | ibuprofen |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021604
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 100MG/5ML | ||||
| Approval Date: | Jan 7, 2004 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
